Group 1 - The core viewpoint of the news highlights the performance of Yingjian Medical (盈健医疗) in the Hong Kong stock market, noting a significant increase in its stock price and a comparison of its financial metrics against industry averages [1] - As of July 23, the Hang Seng Index rose by 1.62%, while Yingjian Medical's stock price increased by 13.95%, closing at HKD 0.98 per share with a trading volume of 1.094 million shares [1] - Over the past month, Yingjian Medical has seen a cumulative increase of 6.17%, but it has underperformed compared to the Hang Seng Index, which has risen by 25.27% year-to-date [1] Group 2 - Financial data indicates that Yingjian Medical achieved total revenue of HKD 292 million for the year ending December 31, 2024, reflecting a year-on-year growth of 6.98%, while its net profit attributable to shareholders decreased by 16.03% to HKD 15.5778 million [1] - The company's gross profit margin stands at 47.09%, and its debt-to-asset ratio is 25.1% [1] - In terms of industry valuation, the average price-to-earnings (P/E) ratio for the healthcare equipment and services sector is -1.96x, with a median of 1.36x, while Yingjian Medical's P/E ratio is 15.56x, ranking 25th in the industry [1]
盈健医疗（01419.HK）7月23日收盘上涨13.95%，成交101.21万港元